{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T18:53:14Z","timestamp":1769021594877,"version":"3.49.0"},"reference-count":24,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2017,6,20]],"date-time":"2017-06-20T00:00:00Z","timestamp":1497916800000},"content-version":"vor","delay-in-days":170,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Leukemia Research Reports"],"published-print":{"date-parts":[[2017]]},"DOI":"10.1016\/j.lrr.2017.07.002","type":"journal-article","created":{"date-parts":[[2017,7,27]],"date-time":"2017-07-27T08:48:23Z","timestamp":1501145303000},"page":"7-10","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["An unusual type of myeloid sarcoma localization following myelofibrosis: A case report and literature review"],"prefix":"10.1016","volume":"8","author":[{"given":"Nicola","family":"Orofino","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniele","family":"Cattaneo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristina","family":"Bucelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Loredana","family":"Pettine","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sonia","family":"Fabris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Umberto","family":"Gianelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicola Stefano","family":"Fracchiolla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Agostino","family":"Cortelezzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandra","family":"Iurlo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.lrr.2017.07.002_bib1","series-title":"WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues","author":"Swerdlow","year":"2008"},{"key":"10.1016\/j.lrr.2017.07.002_bib2","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1182\/blood-2016-03-643544","article-title":"The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia","volume":"127","author":"Arber","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.lrr.2017.07.002_bib3","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.clml.2017.02.027","article-title":"Myeloid sarcoma: presentation, diagnosis, and treatment","volume":"17","author":"Almond","year":"2017","journal-title":"Clin. Lymphoma Myeloma Leuk."},{"key":"10.1016\/j.lrr.2017.07.002_bib4","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1038\/sj.leu.2404491","article-title":"Myeloid sarcoma: clinico-pathologic, phenotypic and cytogenetic analysis of 92 adult patients","volume":"21","author":"Pileri","year":"2007","journal-title":"Leukemua"},{"key":"10.1016\/j.lrr.2017.07.002_bib5","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1097\/PAS.0000000000000727","article-title":"Clinicopathological, cytogenetic, and prognostic analysis of 131 myeloid sarcoma patients","volume":"40","author":"Kawamoto","year":"2016","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.lrr.2017.07.002_bib6","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.3324\/haematol.2011.045047","article-title":"18F-FDG-PET\/CT for detection of extramedullary acute myeloid leukemia","volume":"96","author":"St\u00f6lzel","year":"2011","journal-title":"Haematologica"},{"key":"10.1016\/j.lrr.2017.07.002_bib7","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1111\/j.1365-2141.2004.05124.x","article-title":"FLT3 mutations in myeloid sarcoma","volume":"126","author":"Ansari-Lari","year":"2004","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.lrr.2017.07.002_bib8","doi-asserted-by":"crossref","DOI":"10.1038\/leu.2017.169","article-title":"A clinical-molecular prognostic model to predict survival in patients with post polycythemia vera and post essential thrombocythemia myelofibrosis","author":"Passamonti","year":"2017","journal-title":"Leukemia"},{"key":"10.1016\/j.lrr.2017.07.002_bib9","first-page":"1128","article-title":"European consensus on grading of bone marrow fibrosis and assessment of cellularity","volume":"90","author":"Thiele","year":"2005","journal-title":"Haematologica"},{"key":"10.1016\/j.lrr.2017.07.002_bib10","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1002\/ajh.24592","article-title":"Primary myelofibrosis: 2017 update on diagnosis, risk-stratification, and management","volume":"91","author":"Tefferi","year":"2016","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.lrr.2017.07.002_bib11","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1038\/leu.2015.81","article-title":"Next-generation sequencing reveals clinically actionable molecular markers in myeloid sarcoma","volume":"29","author":"Li","year":"2015","journal-title":"Leukemia"},{"key":"10.1016\/j.lrr.2017.07.002_bib12","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1182\/blood-2014-05-578435","article-title":"Clinical effect of driver mutations of JAK2, CALR, or MPL in primary myelofibrosis","volume":"124","author":"Rumi","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.lrr.2017.07.002_bib13","doi-asserted-by":"crossref","first-page":"5022","DOI":"10.18632\/oncotarget.3217","article-title":"CXCR4 over-expression and survival in cancer: a system review and meta-analysis","volume":"6","author":"Zhao","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.lrr.2017.07.002_bib14","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1038\/sj.leu.2402341","article-title":"Abnormality of c-kit oncoprotein in certain patients with chronic myelogenous leukemia: potential clinical significance","volume":"16","author":"Inokuchi","year":"2002","journal-title":"leukemia"},{"key":"10.1016\/j.lrr.2017.07.002_bib15","doi-asserted-by":"crossref","first-page":"4665","DOI":"10.18632\/oncotarget.1941","article-title":"Identification of kit (M541L) somatic mutation in chronic eosinophili leukemia, not otherwise specified and its implication in low-dose imatinib response","volume":"5","author":"Iurlo","year":"2014","journal-title":"Oncotarget"},{"key":"10.1016\/j.lrr.2017.07.002_bib16","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1159\/000253592","article-title":"Prognostic factors of treatment outcomes in patients with granulocitic sarcoma","volume":"122","author":"Lan","year":"2009","journal-title":"Acta Haematol."},{"key":"10.1016\/j.lrr.2017.07.002_bib17","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1182\/blood-2006-05-024844","article-title":"CXCR4 is a prognostic marker in acute myelogenous leukemia","volume":"109","author":"Spoo","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.lrr.2017.07.002_bib18","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.leukres.2016.12.003","article-title":"Clinical outcome of myeloid sarcoma in adult patients and effect of allogeneic stem cell transplantation. Results from a multicenter survey","volume":"53","author":"Lazzarotto","year":"2017","journal-title":"Leuk. Res."},{"key":"10.1016\/j.lrr.2017.07.002_bib19","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1007\/s00277-016-2870-0","article-title":"Evidence for a role of decitabine in the treatment of myeloid sarcoma","volume":"96","author":"Gornicec","year":"2017","journal-title":"Ann. Hematol."},{"key":"10.1016\/j.lrr.2017.07.002_bib20","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1038\/bmt.2011.210","article-title":"Durable complete remission after single agent decitabine in AML relapsing in extramedullary sites after allo-SCT","volume":"47","author":"Singh","year":"2012","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.lrr.2017.07.002_bib21","first-page":"9574","article-title":"primary vaginal myeloid sarcoma: a rare case report and review of the literature","author":"Modi","year":"2015","journal-title":"Case Rep. Obstet. Gynecol."},{"key":"10.1016\/j.lrr.2017.07.002_bib22","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1111\/1754-9485.12172","article-title":"Treatment outcomes for patients with chloroma receiving radiation therapy","volume":"58","author":"Hall","year":"2014","journal-title":"J. Med. Imaging Radiat. Oncol."},{"key":"10.1016\/j.lrr.2017.07.002_bib23","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1038\/sj.leu.2402958","article-title":"Outcome in patients with nonleukemic granulocytic sarcoma treated with chemotherapy with or without radiotherapy","volume":"17","author":"Tsimberidou","year":"2003","journal-title":"Leukemia"},{"key":"10.1016\/j.lrr.2017.07.002_bib24","doi-asserted-by":"crossref","first-page":"3785","DOI":"10.1182\/blood-2011-04-347229","article-title":"How I treat extramedullary acute myeloid leukemia","volume":"118","author":"Bakst","year":"2011","journal-title":"Blood"}],"container-title":["Leukemia Research Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213048917300316?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213048917300316?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T01:07:33Z","timestamp":1761959253000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213048917300316"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017]]},"references-count":24,"alternative-id":["S2213048917300316"],"URL":"https:\/\/doi.org\/10.1016\/j.lrr.2017.07.002","relation":{},"ISSN":["2213-0489"],"issn-type":[{"value":"2213-0489","type":"print"}],"subject":[],"published":{"date-parts":[[2017]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"An unusual type of myeloid sarcoma localization following myelofibrosis: A case report and literature review","name":"articletitle","label":"Article Title"},{"value":"Leukemia Research Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lrr.2017.07.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}